JW Life Science

JW Life Science EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JW Life Science (234080.KS) as of Oct 20, 2026 is 33.24 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 36.35 B KRW — a change of -8.54% (lower).

EBITDA

33.24 BKRW

YoY

-8.54%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JW Life Science is 2025 33.24 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JW Life Science was 2024 36.35 B KRW. It decreases by -8.54% lower compared to the previous year.

The JW Life Science EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
24.22 B KRW
Jan 1, 2018
24.06 B KRW
Jan 1, 2019
30.79 B KRW
Jan 1, 2020
40.70 B KRW
Jan 1, 2021
29.72 B KRW
Jan 1, 2022
28.70 B KRW
Jan 1, 2023
36.35 B KRW
Jan 1, 2025
33.24 B KRW
The JW Life Science EBITDA history
YEAREBITDAYoY
33.24 BKRW-8.54%
36.35 BKRW+26.63%
28.70 BKRW-3.40%
29.72 BKRW-26.99%
40.70 BKRW+32.20%
30.79 BKRW+27.97%
24.06 BKRW-0.67%
24.22 BKRW+9.94%
22.03 BKRW+15.83%
19.02 BKRW+26.87%
14.99 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JW Life Science Stock analysis

What does JW Life Science do? JW Life Science Corp. manufactures intravenous fluids including basic IV fluids with water, electrolytes, and glucose, nutrient infusion solutions containing amino acids, lipids, proteins, vitamins, and minerals, and special infusion solutions for specific medical cases. The company produces total parenteral nutrition (TPN) products as part of its manufacturing focus. The primary buyers of these products are healthcare providers and hospitals requiring intravenous treatments for patient care. The company serves the medical sector by providing essential fluid and nutrition solutions for clinical use. The firm's product segments are defined by the types of IV fluids and TPN solutions they produce, targeting healthcare institutions that administer intravenous therapies. Basic IV fluids are used for general hydration and electrolyte balance, while nutrient infusion solutions support patient nutrition in critical care settings. Special infusion solutions address unique medical conditions requiring tailored treatments. The company's offerings are integral to hospital and clinic operations in delivering patient care. JW Life Science Corp. generates revenue through the sale of its manufactured intravenous fluid products to healthcare facilities. The company's business model relies on consistent demand for IV fluids and TPN solutions within the medical industry. Its products are distributed to hospitals and clinics that require these essential medical supplies for patient treatment protocols. JW Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JW Life Science stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JW Life Science is 33.24 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of JW Life Science changed from 36.35 B KRW to 33.24 B KRW, representing a -8.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) JW Life Science since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JW Life Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — JW Life Science

All Key Metrics — JW Life Science